Thank you for that welcome and your words of introduction. I am delighted to have the opportunity to present and introduce the report and answer questions on it this morning.
I begin in the same spirit as that in which you have begun, which is to build on some of the significant achievements in Scotland and on Scotland’s wider influence in the world of palliative care. I do not want to digress too much into a history lesson, but it is not widely known that the first ever home for the dying in the United Kingdom was established by a woman from Donside in Aberdeenshire, Frances Davidson, who moved to the east end of London and opened a home for the dying there in 1885.
During the 20th century, we have seen developments in hospice services in Scotland and the growth in interest in and influence of some of the major charities, particularly Marie Curie and Macmillan Cancer Support. We have also seen a key role in the formation of what we call the modern hospice movement, which sees hospice care as not just about the delivery of excellent care to people who are in need, but about education, research and wider engagement with society. I pay tribute to Dr Derek Doyle, who was the first medical director of St Columba’s Hospice in Edinburgh and who was instrumental in gaining recognition for palliative medicine as a medical specialty in Britain in the 1980s. He went on to be a major advocate for palliative care around the world.
There is quite a lot to celebrate about the contribution that Scotland has made to the field of palliative and hospice care, and about the resources that we have available to deliver care to people in our country. However, the situation in Scotland is quite different from that in the wider global context. Over time, I have tried to analyse the development of palliative care in all the countries of the world. As members will have seen in the report, we estimate that only 20 countries have an advanced level of palliative care development. We refer to things such as the availability of appropriate drugs for pain and symptom management, the provision of services in acute and community settings, the provision of education programmes, the existence of a body of research and, perhaps most important, underpinning policies and strategy on the part of Governments to support the development and delivery of palliative care.
Very few countries in the world are kitted out with those elements. Indeed, the World Health Organization very recently estimated that probably only 14 per cent of the world’s population who need palliative care get any access to it.
We live in changing times and we have to continue to review what we are doing, even in countries with well-developed palliative care. The key element of that discussion is that we are moving from hospice and palliative care being seen as the business of specialists of one sort or another—the people who have spearheaded the development of the field—to hospice, palliative and end-of-life care becoming everybody’s business. It is becoming more the business of generalists. In a wider context, there is a concern that we should all engage with it as an aspect of civil society and the wider society and communities in which we live.
It is time to take stock of where we have got to. There are lots of good things to acknowledge and celebrate, but we need to ask how much palliative care we are delivering and whether we are properly resourced to do that. My report tries to set out how we go about exploring that question and the indicators that we would need in order to provide some answers. Those indicators are to do with the supply of services, the need that those services are oriented to meet, the extent to which we have good access for and complete coverage of all those who need palliative care and, perhaps most critical and difficult of all, what we know about the outcomes of the care that is provided. How good is it? Is it appropriate? Is it well received by those to whom it is delivered? What is its quality?
My conclusion is that Scotland has problems in giving clear answers to such questions—and we are not alone in that—but I have tried to offer some solutions that we might explore in order to be better equipped to address those issues. When questions along the lines of “How good is palliative care in our country?” are quite reasonably put, we need to be better equipped to deliver fairly succinct but robust answers to them.
I recommend a number of things, on which I would be happy to elaborate. First, we need a reasonably robust mapping exercise of the delivery of specialist palliative care in Scotland. As I said in my report, we are unable to model palliative care delivery in Scotland against that in other countries because all the reporting takes place in a context in which Scottish data is buried within data for the United Kingdom as a whole. The time has come to create an atlas entry, if you like, that would allow us to compare palliative care in Scotland with palliative care in countries that have a similar population and are of a similar type.
The second thing worth doing would be to conduct a systematic review of the research on palliative care that has been done in Scotland, assess the research’s quality and get more lessons and action points out of it than we currently do. Such an exercise was done in Ireland recently. Good work is going on in our universities, some of which is not very well known. By systematically reviewing that work, we could do a lot more to learn from it and disseminate the results the more widely. It is not uncommon for a person who is involved in research in the field to be somewhat disappointed when they talk to people about work that they have done, which they thought was well known, and find that some of the intended audience is still unaware of it, through no fault of their own. A systematic review and a wide dissemination of the work that has been conducted in recent years would be extremely useful.
We also need more investment in measuring the ways in which we identify people who could benefit from palliative care. In my report I distinguish between the public health question of how many people need palliative care and the clinical question of how we identify those people when we are in front of them and referring them to appropriate services. As I have highlighted, colleagues here at the University of Edinburgh and in the Lothian region are developing a good measure—the supportive and palliative care indicators tool, or SPICT—but it is still at a relatively early stage of development. More work needs to be done on refining such measures to enable clinicians quickly and accurately to identify patients and families who would benefit from palliative care and could be referred to it, whether that is specialist care or care that can be provided by general physicians, general practitioners and the wider health and social care team.
Finally, we need to agree on the appropriate quality indicators that we would like to assess the robustness of palliative care of all stripes as it is delivered in Scotland, and we need to invest in measures that will allow us to gather the data to support those indicators and to disseminate them and learn from them.